Ocular Therapeutix™ to Participate at Two Upcoming Investor Conferences
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences: Raymond James SMID Cap Company Showcase Date: Friday, November 13, 2020 Ocular Therapeutix™ to host investor one-on-one meetings Jefferies Virtual London Healthcare Conference Date: Thursday, November